NAMS MENOPAUSE CERTIFICATION EXAM (MSCP)
QUESTIONS AND CORRECT ANSWERS (VERIFIED
ANSWERS) PLUS RATIONALES 2026/2027 | INSTANT
DOWNLOAD PDF
Core Domains
• Physiology and Pathophysiology of Menopause Transition
• Symptoms and Concerns of Menopause
• Health Disorders in Midlife Women
• Treatment Options for Menopause
• Preventive Care and Counseling
Introduction
This examination assesses the candidate's advanced knowledge
of menopause management required for Menopause Society
Certified Practitioner credentialing. It evaluates competency in
reproductive aging physiology, vasomotor symptom
management, genitourinary syndrome of menopause, bone
health, cardiovascular risk, and evidence-based hormone and
non-hormonal therapies. Questions include multiple-choice and
scenario-based formats designed to test clinical judgment and
decision-making. Candidates must demonstrate mastery of
STRAW+10 staging, hormone therapy risks and benefits, and
preventive care for midlife women.
Section One: Questions 1–100
1. What is the "climacteric phase"?
,A. The final menstrual period
B. The period of endocrinologic, somatic, and transitory
psychologic changes around the time of menopause
C. The perimenopause only
D. The postmenopausal period
B. The period of endocrinologic, somatic, and transitory
psychologic changes around the time of menopause
RATIONALE: The climacteric phase is the broad period of
endocrine, physical, and psychological changes that occur as a
woman transitions from reproductive to non-reproductive status.
It is a more inclusive term than perimenopause or menopause .
2. Anti-Müllerian hormone (AMH) levels:
A. Increase after menopause
B. Remain stable until menopause then drop
C. Decline progressively with age and become undetectable
after menopause
D. Fluctuate with the menstrual cycle
C. Decline progressively with age and become undetectable
after menopause
RATIONALE: AMH is produced by granulosa cells of
small antral follicles and declines progressively with age,
becoming undetectable after menopause. Unlike FSH, AMH has
minimal cycle-to-cycle variability, making it a reliable marker
of ovarian reserve .
3. Which of the following best defines menopause?
,A. The period of declining ovarian function lasting 5-8 years
before the final menstrual period
B. Twelve consecutive months of amenorrhea following the
final menstrual period
C. The entire lifespan phase from the onset of irregular
menstruation until death
D. The time when a woman experiences her first hot flash
B. Twelve consecutive months of amenorrhea following the
final menstrual period
RATIONALE: Menopause is defined clinically as the final
menstrual period, confirmed retrospectively after 12 consecutive
months without menstruation .
4. What is the definition of "early menopause"?
A. LMP before age 40
B. LMP before age 45
C. LMP before age 50
D. LMP after age 55
B. LMP before age 45
RATIONALE: Early menopause is defined as the last
menstrual period (LMP) occurring before age 45. It is
distinguished from primary ovarian insufficiency (POI), which
occurs before age 40 .
5. According to the STRAW+10 staging system, what
characterizes "early menopause transition" (stage −2)?
A. 60 or more consecutive days of amenorrhea
B. Persistent difference of 7 days or more in the length of
, consecutive cycles
C. Heavy menstrual bleeding
D. Regular cycles 26-35 days
B. Persistent difference of 7 days or more in the length of
consecutive cycles
RATIONALE: Stage −2 (early menopause transition) is
marked by persistent difference of ≥7 days in the length of
consecutive cycles and is when cycle irregularity begins .
6. Which is true about the postmenopausal ovary?
A. It is completely inactive
B. It continues to produce testosterone
C. It produces estradiol equivalent to premenopausal levels
D. It produces only progesterone
B. It continues to produce testosterone
RATIONALE: The postmenopausal ovary continues to
produce androstenedione and testosterone, but minimal estradiol
due to loss of aromatase activity .
7. What is the average age of natural menopause in North
American women?
A. 45 years
B. 48 years
C. 51 years
D. 55 years
C. 51 years
RATIONALE: The median age for menopause is
QUESTIONS AND CORRECT ANSWERS (VERIFIED
ANSWERS) PLUS RATIONALES 2026/2027 | INSTANT
DOWNLOAD PDF
Core Domains
• Physiology and Pathophysiology of Menopause Transition
• Symptoms and Concerns of Menopause
• Health Disorders in Midlife Women
• Treatment Options for Menopause
• Preventive Care and Counseling
Introduction
This examination assesses the candidate's advanced knowledge
of menopause management required for Menopause Society
Certified Practitioner credentialing. It evaluates competency in
reproductive aging physiology, vasomotor symptom
management, genitourinary syndrome of menopause, bone
health, cardiovascular risk, and evidence-based hormone and
non-hormonal therapies. Questions include multiple-choice and
scenario-based formats designed to test clinical judgment and
decision-making. Candidates must demonstrate mastery of
STRAW+10 staging, hormone therapy risks and benefits, and
preventive care for midlife women.
Section One: Questions 1–100
1. What is the "climacteric phase"?
,A. The final menstrual period
B. The period of endocrinologic, somatic, and transitory
psychologic changes around the time of menopause
C. The perimenopause only
D. The postmenopausal period
B. The period of endocrinologic, somatic, and transitory
psychologic changes around the time of menopause
RATIONALE: The climacteric phase is the broad period of
endocrine, physical, and psychological changes that occur as a
woman transitions from reproductive to non-reproductive status.
It is a more inclusive term than perimenopause or menopause .
2. Anti-Müllerian hormone (AMH) levels:
A. Increase after menopause
B. Remain stable until menopause then drop
C. Decline progressively with age and become undetectable
after menopause
D. Fluctuate with the menstrual cycle
C. Decline progressively with age and become undetectable
after menopause
RATIONALE: AMH is produced by granulosa cells of
small antral follicles and declines progressively with age,
becoming undetectable after menopause. Unlike FSH, AMH has
minimal cycle-to-cycle variability, making it a reliable marker
of ovarian reserve .
3. Which of the following best defines menopause?
,A. The period of declining ovarian function lasting 5-8 years
before the final menstrual period
B. Twelve consecutive months of amenorrhea following the
final menstrual period
C. The entire lifespan phase from the onset of irregular
menstruation until death
D. The time when a woman experiences her first hot flash
B. Twelve consecutive months of amenorrhea following the
final menstrual period
RATIONALE: Menopause is defined clinically as the final
menstrual period, confirmed retrospectively after 12 consecutive
months without menstruation .
4. What is the definition of "early menopause"?
A. LMP before age 40
B. LMP before age 45
C. LMP before age 50
D. LMP after age 55
B. LMP before age 45
RATIONALE: Early menopause is defined as the last
menstrual period (LMP) occurring before age 45. It is
distinguished from primary ovarian insufficiency (POI), which
occurs before age 40 .
5. According to the STRAW+10 staging system, what
characterizes "early menopause transition" (stage −2)?
A. 60 or more consecutive days of amenorrhea
B. Persistent difference of 7 days or more in the length of
, consecutive cycles
C. Heavy menstrual bleeding
D. Regular cycles 26-35 days
B. Persistent difference of 7 days or more in the length of
consecutive cycles
RATIONALE: Stage −2 (early menopause transition) is
marked by persistent difference of ≥7 days in the length of
consecutive cycles and is when cycle irregularity begins .
6. Which is true about the postmenopausal ovary?
A. It is completely inactive
B. It continues to produce testosterone
C. It produces estradiol equivalent to premenopausal levels
D. It produces only progesterone
B. It continues to produce testosterone
RATIONALE: The postmenopausal ovary continues to
produce androstenedione and testosterone, but minimal estradiol
due to loss of aromatase activity .
7. What is the average age of natural menopause in North
American women?
A. 45 years
B. 48 years
C. 51 years
D. 55 years
C. 51 years
RATIONALE: The median age for menopause is
